| Application no. and date | 14197779.3 (espacenet) (Federated) (European Patent Register), 20080926 | | Patent/reg. no. and date | DK/EP 2915564, 20201104 | | Publication date | 20150909 | | Priority no. and date | US 976343 P, 20070928, US 90574 P, 20080820 | | EP pub. no. and date |
EP 2915564 20150909 | | Effective date | | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | | Applicant ref. no. | 1579584 | | Inventor | LU, Genmin, 1439 El Camino Real Apt.9
Burlingame, CA California 94010, US,
ANDRE, Patrick, 950 N.Humbolt Street
San Francisco, CA California 94401, US,
SINHA, Uma, 808 Junipero Serra Boulevard
San Francisco, CA California 94127, US,
PHILLIPS, David R., 415 W. Santa Inez Avenue
Hillsborough, CA 94010, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61P 7/04 (2006.01) | | Title | Antidoter mod faktor XA-inhibitorer og fremgangsmåder til anvendelse deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
